NHS Accelerated Access Collaborative
Overview
The NHS Accelerated Access Collaborative (AAC) brings together industry, government, regulators, patients and the NHS to remove barriers and accelerate the introduction of ground-breaking new treatments and diagnostics which can transform care. The AAC supports all types of innovations: medicines, diagnostics, devices, digital products, pathway changes and new workforce models.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ultromics | Sep 2020 | Grant | Co-investor |
| Skin Analytics | Jul 2023 | Grant | Co-investor |
| PinPoint Data Science | Feb 2022 | Grant | Co-investor |
| SPRYT | Feb 2025 | Grant | Co-investor |
| Lucida Medical | Jul 2024 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NHS Accelerated Access Collaborative based?
NHS Accelerated Access Collaborative is headquartered in London, England, United Kingdom.
When was NHS Accelerated Access Collaborative founded?
NHS Accelerated Access Collaborative was founded in 2018.
How many portfolio companies does NHS Accelerated Access Collaborative have?
NHS Accelerated Access Collaborative has 30 portfolio companies in Caplight's dataset.
What are some companies in NHS Accelerated Access Collaborative's portfolio?
Portfolio companies visible on Caplight include Ultromics, Skin Analytics, PinPoint Data Science, SPRYT, Lucida Medical.
What was NHS Accelerated Access Collaborative's most recent investment shown here?
NHS Accelerated Access Collaborative's most recent investment in this portfolio sample was in SPRYT in 2025.
What sectors does NHS Accelerated Access Collaborative focus on?
NHS Accelerated Access Collaborative focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Media, Entertainment & Gaming, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech.
What company stages does NHS Accelerated Access Collaborative focus on?
NHS Accelerated Access Collaborative typically invests at the MultiStage stage.
What is NHS Accelerated Access Collaborative's AUM?
NHS Accelerated Access Collaborative's assets under management are estimated between $250.0M and $500.0M.